Short QT syndrome or Andersen syndrome: Yin and Yang of Kir2.1 channel dysfunction

Circulation Research

Volumn 96, Issue 7, 2005, Pages 703-704

  Schulze Bahr, Eric ^a,b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Andersen syndrome; Gene; KCNJ2; Mutation; Short QT syndrome; Ventricular fibrillation

Indexed keywords

INWARDLY RECTIFYING POTASSIUM CHANNEL; POTASSIUM CHANNEL;

CARBOXY TERMINAL SEQUENCE; ECG ABNORMALITY; EDITORIAL; GENE; GENE MUTATION; GENETIC LINKAGE; GENETIC TRAIT; HEART ARRHYTHMIA; HEART REPOLARIZATION; HETEROLOGOUS EXPRESSION; KCNJ2 GENE; MEMBRANE BINDING; MEMBRANE STEADY POTENTIAL; MULTIGENE FAMILY; PHENOTYPE; POTASSIUM CHANNEL KIR2.1; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; SHORT QT SYNDROME; SIGNAL TRANSDUCTION; T WAVE; TERATOLOGY;

ARRHYTHMIA; ELECTROCARDIOGRAPHY; HUMANS; MUTATION; POTASSIUM CHANNELS, INWARDLY RECTIFYING; SYNDROME; YIN-YANG;

EID: 17644399838     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000164186.86838.09     Document Type: Editorial

References (11)

1. Miake J, Marban E, Nuss HB. Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression. J Clin Invest. 2003;111:1529-1536.
2. Preisig-Muller R, Schlichthorl G, Goerge T, Heinen S, Bruggemann A, Rajan S, Derst C, Veh RW, Daut J. Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome. Proc Natl Acad Sci U S A. 2002;99:7774-7779.
3. Plaster NM, Tawil R, Tristani-Firouzi M, Canun S, Bendahhou S, Tsunoda A, Donaldson MR, Iannaccone ST, Brunt E, Barohn R, Clark J, Deymeer F, George AL, Jr., Fish FA, Hahn A, Nitu A, Ozdemir C, Serdaroglu P, Subramony SH, Wolfe G, Fu YH, Ptacek LJ. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell. 2001;105:511-519.
4. Tristani-Firouzi M, Jensen JL, Donaldson MR, Sansone V, Meola G, Hahn A, Bendahhou S, Kwiecinski H, Fidzianska A, Plaster N, Fu YH, Ptacek LJ, Tawil R. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest. 2002;110:381-388.
5. Andelfinger G, Tapper AR, Welch RC, Vanoye CG, George Jr AL, Benson DW. KCNJ2 Mutation Results in Andersen Syndrome with Sex-Specific Cardiac and Skeletal Muscle Phenotypes. Am J Hum Genet. 2002;71:663-668.
6. Junker J, Haverkamp W, Schulze-Bahr E, Eckardt L, Paulus W, Kiefer R. Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome. Neurology. 2002;59:466.
7. Donaldson MR, Jensen JL, Tristani-Firouzi M, Tawil R, Bendahhou S, Suarez WA, Cobo AM, Poza JJ, Behr E, Wagstaff J, Szepetowski P, Pereira S, Mozaffar T, Escolar DM, Fu YH, Ptacek LJ. PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome. Neurology. 2003;60:1811-1816.
8. Priori SG, Pandit SV, Rivolta I, Berenfeld O, Ronchetti E, Dhamoon A, Napolitano C, Anumonwo J, Raffaele dB, Gudapakkam S, Bosi G, Stramba-Badiale M, Jalife J. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res. 2005;96:800-807.
9. Schulze-Bahr E, Breithardt G. Short-QT interval and short-QT syndromes. Journal of Cardiovascular Electrophysiology. 2005;16:1-3.
10. Brugada R, Hong K, Dumaine R, Cordeiro J, Gaita F, Borggrefe M, Menendez TM, Brugada J, Pollevick GD, Wolpert C, Burashnikov E, Matsuo K, Wu YS, Guerchicoff A, Bianchi F, Giustetto C, Schimpf R, Brugada P, Antzelevitch C. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation. 2004;109:30-35.
11. Bellocq C, van Ginneken ACG, Bezzina CR, Alders M, Escande D, Mannens MMAM, Baro I, Wilde AAM. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation. 2004;109:2394-2397.